{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:51:39Z","timestamp":1791427899203,"version":"4.3.3"},"reference-count":96,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.tibtech.2015.09.008","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T17:32:51Z","timestamp":1445707971000},"page":"777-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":133,"title":["Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery"],"prefix":"10.1016","volume":"33","author":[{"given":"Christian J.","family":"Buchholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Friedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard","family":"B\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2015.09.008_bib0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev-med-060512-150254","article-title":"Chimeric antigen receptor therapy for cancer","volume":"65","author":"Barrett","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0010","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/emmm.201202287","article-title":"Gene therapy on the move","volume":"5","author":"Kaufmann","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrg2985","article-title":"Ex vivo gene transfer and correction for cell-based therapies","volume":"12","author":"Naldini","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/mt.2008.288","article-title":"MicroRNAs and the regulation of vector tropism","volume":"17","author":"Kelly","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/tan.12002","article-title":"Exploiting microRNA regulation for genetic engineering","volume":"80","author":"Gentner","year":"2012","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.exphem.2010.04.016","article-title":"Gene transfer into human cord blood-derived CD34+ cells by adeno-associated viral vectors","volume":"38","author":"Schuhmann","year":"2010","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/hum.2011.058","article-title":"Lentiviral vectors: their molecular design, safety, and use in laboratory and preclinical research","volume":"22","author":"Dropuli\u0107","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0040","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/mt.2011.287","article-title":"The AAV vector toolkit: poised at the clinical crossroads","volume":"20","author":"Asokan","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0045","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrg2141","article-title":"Engineering targeted viral vectors for gene therapy","volume":"8","author":"Waehler","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/138620708783744543","article-title":"Retroviral display and high throughput screening","volume":"11","author":"Buchholz","year":"2008","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0055","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/mt.2014.14","article-title":"Tropism-modified AAV vectors overcome barriers to successful cutaneous therapy","volume":"22","author":"Sallach","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0060","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nm1192","article-title":"Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection","volume":"11","author":"Morizono","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nbt1060","article-title":"Rescue and propagation of fully retargeted oncolytic measles viruses","volume":"23","author":"Nakamura","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0070","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/mt.2008.128","article-title":"Targeted cell entry of lentiviral vectors","volume":"16","author":"Funke","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2174\/156652308786848003","article-title":"Strategies for targeting lentiviral vectors","volume":"8","author":"Frecha","year":"2008","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tibtech.2009.02.002","article-title":"Lentiviral vectors with measles virus glycoproteins \u2013 dream team for gene transfer?","volume":"27","author":"Buchholz","year":"2009","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0085","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1016\/j.biomaterials.2014.01.051","article-title":"Systematic improvement of lentivirus transduction protocols by antibody fragments fused to VSV-G as envelope glycoprotein","volume":"35","author":"H\u00f6fig","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0090","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1128\/JVI.76.9.4559-4566.2002","article-title":"Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors","volume":"76","author":"Ried","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev-pharmtox-010611-134654","article-title":"Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy","volume":"55","author":"Pl\u00fcckthun","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/mt.2012.186","article-title":"Displaying high-affinity ligands on adeno-associated viral vectors enables tumor cell-specific and safe gene transfer","volume":"21","author":"M\u00fcnch","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0105","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/mt.2010.298","article-title":"DARPins: an efficient targeting domain for lentiviral vectors","volume":"19","author":"M\u00fcnch","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0110","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/j.vaccine.2012.03.079","article-title":"High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors","volume":"30","author":"Aslanidi","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0115","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/mt.2012.144","article-title":"Terminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteins","volume":"20","author":"Lovric","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0120","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1038\/ncomms7246","article-title":"Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors","volume":"6","author":"M\u00fcnch","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nmeth.1514","article-title":"Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors","volume":"7","author":"Anliker","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/mt.2014.173","article-title":"CD133-targeted gene transfer into long-term repopulating hematopoietic stem cells","volume":"23","author":"Brendel","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0135","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1089\/scd.2014.0455","article-title":"CD105 is a surface marker for receptor-targeted gene transfer into human long-term repopulating hematopoietic stem cells","volume":"24","author":"Kays","year":"2015","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0140","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1089\/hum.2012.123","article-title":"Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients","volume":"23","author":"Colella","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0145","doi-asserted-by":"crossref","first-page":"189ra76","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/mt.2014.154","article-title":"Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV restores ON and OFF visual responses in blind mice","volume":"23","author":"Mac\u00e9","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0155","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1182\/blood-2012-11-468579","article-title":"Specific gene delivery to liver sinusoidal and artery endothelial cells","volume":"122","author":"Abel","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0160","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1182\/blood-2012-02-412973","article-title":"T-cell receptor gene transfer exclusively to human CD8+ cells enhances tumor cell killing","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0165","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.4049\/jimmunol.1500956","article-title":"Exclusive transduction of human CD4+ T cells upon systemic delivery of CD4-targeted lentiviral vectors","volume":"195","author":"Zhou","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrg3742","article-title":"Engineering adeno-associated viruses for clinical gene therapy","volume":"15","author":"Kotterman","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0175","doi-asserted-by":"crossref","first-page":"e5122","DOI":"10.1371\/journal.pone.0005122","article-title":"Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries","volume":"4","author":"Michelfelder","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0180","article-title":"Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors","author":"Trepel","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0185","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/hum.2010.060","article-title":"Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application","volume":"22","author":"Merten","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0190","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-0-12-386509-0.00012-0","article-title":"Adeno-associated virus vectorology, manufacturing, and clinical applications","volume":"507","author":"Grieger","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0195","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/mt.2011.138","article-title":"Protein transfer into human cells by VSV-G-induced nanovesicles","volume":"19","author":"Mangeot","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/protein\/gzv005","article-title":"Receptor-targeted lentiviral vectors are exceptionally sensitive toward the biophysical properties of the displayed single-chain Fv","volume":"28","author":"Friedel","year":"2015","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/gt.2014.125","article-title":"A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins","volume":"22","author":"Marino","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0210","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/gt.2013.23","article-title":"Characterization of a third generation lentiviral vector pseudotyped with Nipah virus envelope proteins for endothelial cell transduction","volume":"20","author":"Witting","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0215","doi-asserted-by":"crossref","unstructured":"Bender, R.R. et al. (2015) Developing an engineered Nipah virus glycoprotein based lentiviral vector system retargeted to cell surface receptors of choice. In ASGCT Conference: Simultaneous Oral Abstract Sessions: RNA Virus Vectors. (http:\/\/www.abstracts2view.com\/asgct\/view.php?nu=ASGCT15L1_4)","DOI":"10.1016\/S1525-0016(16)33608-5"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0220","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg3899","article-title":"High-throughput functional genomics using CRISPR-Cas9","volume":"16","author":"Shalem","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nbt.3055","article-title":"In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9","volume":"33","author":"Swiech","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0230","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.1214441110","article-title":"LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus","volume":"110","author":"Finkelshtein","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0235","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2013-11-540641","article-title":"Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor","volume":"123","author":"Amirache","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0240","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1182\/blood-2008-05-155945","article-title":"Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins","volume":"112","author":"Frecha","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0245","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2009-05-220798","article-title":"Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors","volume":"114","author":"Frecha","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0250","doi-asserted-by":"crossref","first-page":"e79047","DOI":"10.1371\/journal.pone.0079047","article-title":"CD19 and CD20 targeted vectors induce minimal activation of resting B lymphocytes","volume":"8","author":"Kneissl","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0255","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virol.2011.02.010","article-title":"Resting lymphocyte transduction with measles virus glycoprotein pseudotyped lentiviral vectors relies on CD46 and SLAM","volume":"413","author":"Zhou","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0260","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1128\/JVI.00324-11","article-title":"Measles virus glycoprotein\u2013pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors","volume":"85","author":"Frecha","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0265","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/gt.2009.11","article-title":"Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity","volume":"16","author":"Funke","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0270","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature10639","article-title":"Adherens junction protein nectin-4 is the epithelial receptor for measles virus","volume":"480","author":"M\u00fchlebach","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0275","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/gt.2012.6","article-title":"Intracellular transport of recombinant adeno-associated virus vectors","volume":"19","author":"Nonnenmacher","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0280","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1128\/JVI.00254-08","article-title":"In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses","volume":"82","author":"Grimm","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0285","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature12875","article-title":"Selection and evaluation of clinically relevant AAV variants in a xenograft liver model","volume":"506","author":"Lisowski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0290","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1128\/JVI.00076-06","article-title":"Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism","volume":"80","author":"Perabo","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0295","doi-asserted-by":"crossref","first-page":"19535","DOI":"10.1073\/pnas.0707830104","article-title":"Crystal structure of measles virus hemagglutinin provides insight into effective vaccines","volume":"104","author":"Hashiguchi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0300","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coviro.2014.01.005","article-title":"Activation of paramyxovirus membrane fusion and virus entry","volume":"5","author":"Jardetzky","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0305","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/978-1-4614-7651-1_6","article-title":"Paramyxovirus entry","volume":"790","author":"Bossart","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0310","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.tcb.2013.09.004","article-title":"HIV trafficking in host cells: motors wanted!","volume":"23","author":"Gaudin","year":"2013","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0315","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/gt.2011.78","article-title":"Successful target cell transduction of capsid-engineered rAAV vectors requires clathrin-dependent endocytosis","volume":"19","author":"Uhrig","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0320","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.virol.2010.09.025","article-title":"Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles","volume":"409","author":"Stahnke","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0325","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.1128\/JVI.00282-12","article-title":"Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry","volume":"86","author":"Popa-Wagner","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0330","doi-asserted-by":"crossref","first-page":"e116114","DOI":"10.1371\/journal.pone.0116114","article-title":"Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells","volume":"9","author":"Bayin","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0335","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/hgtb.2012.054","article-title":"Specific targeting of human interleukin (IL)-13 receptor \u03b12-positive cells with lentiviral vectors displaying IL-13","volume":"23","author":"Ou","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0340","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1089\/hum.2010.184","article-title":"Lentiviral vectors targeted to MHC II are effective in immunization","volume":"22","author":"Ageichik","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0345","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1476-4598-11-81","article-title":"In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens","volume":"11","author":"Lafitte","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0350","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1038\/sj.mt.6300271","article-title":"A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration","volume":"15","author":"Pariente","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0355","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jgm.1290","article-title":"Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells","volume":"11","author":"Liang","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0360","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jgm.1151","article-title":"Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors","volume":"10","author":"Pariente","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0365","doi-asserted-by":"crossref","first-page":"e34778","DOI":"10.1371\/journal.pone.0034778","article-title":"Antibody-directed lentiviral gene transduction for live-cell monitoring and selection of human iPS and hES cells","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0370","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/mt.2014.49","article-title":"Specific retrograde transduction of spinal motor neurons using lentiviral vectors targeted to presynaptic NMJ receptors","volume":"22","author":"Eleftheriadou","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0375","doi-asserted-by":"crossref","first-page":"e76092","DOI":"10.1371\/journal.pone.0076092","article-title":"Preferential lentiviral targeting of astrocytes in the central nervous system","volume":"8","author":"Fassler","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0380","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1039\/C4CC03292F","article-title":"A chemical switch for controlling viral infectivity","volume":"50","author":"H\u00f6rner","year":"2014","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0385","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1038\/srep03759","article-title":"Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy","volume":"4","author":"Hagen","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0390","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/jgm.1392","article-title":"Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations","volume":"11","author":"Boucas","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0395","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1525-0016(03)00123-0","article-title":"In vitro selection of viral vectors with modified tropism: the adeno-associated virus display","volume":"8","author":"Perabo","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0400","doi-asserted-by":"crossref","first-page":"e23101","DOI":"10.1371\/journal.pone.0023101","article-title":"Peptide ligands incorporated into the threefold spike capsid domain to re-direct gene transduction of AAV8 and AAV9 in vivo","volume":"6","author":"Michelfelder","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0405","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1479-0556-6-12","article-title":"Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line","volume":"6","author":"Stiefelhagen","year":"2008","journal-title":"Genet. Vaccines Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0410","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.exphem.2008.03.007","article-title":"Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells","volume":"36","author":"Sellner","year":"2008","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0415","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/mthe.2001.0424","article-title":"Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells","volume":"4","author":"Nicklin","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0420","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/nbt856","article-title":"Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors","volume":"21","author":"M\u00fcller","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0425","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/01.CIR.0000109697.68832.5D","article-title":"Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors","volume":"109","author":"White","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0430","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/jgm.967","article-title":"Isolation of targeted AAV2 vectors from novel virus display libraries","volume":"8","author":"Waterkamp","year":"2006","journal-title":"J. Gene Med."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0435","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gt.2011.143","article-title":"Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors","volume":"19","author":"Varadi","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0440","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ymthe.2005.11.013","article-title":"Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses","volume":"13","author":"Work","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0445","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.15252\/emmm.201404077","article-title":"Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter","volume":"6","author":"Cronin","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0450","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ymthe.2003.11.006","article-title":"Development of efficient viral vectors selective for vascular smooth muscle cells","volume":"9","author":"Work","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0455","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/gt.2010.44","article-title":"Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library","volume":"17","author":"Ying","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0460","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fimmu.2015.00120","article-title":"Adeno-associated viral vectors at the frontier between tolerance and immunity","volume":"6","author":"Mingozzi","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0465","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0470","doi-asserted-by":"crossref","first-page":"e46667","DOI":"10.1371\/journal.pone.0046667","article-title":"Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies","volume":"7","author":"Kneissl","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tibtech.2015.09.008_bib0475","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/mt.2012.96","article-title":"Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells","volume":"20","author":"L\u00e9vy","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2015.09.008_bib0480","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1038\/sj.gt.3302123","article-title":"Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies","volume":"10","author":"Huttner","year":"2003","journal-title":"Gene Ther."}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779915001948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779915001948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T22:15:46Z","timestamp":1567289746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779915001948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":96,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0167779915001948"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2015.09.008","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2015.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}